−0.006SEK
−438.00 KSEK
50.49 MSEK
5.10 M
About SPRINT BIOSCIENCE AB
Sector
CEO
Johan Emilsson
Headquarters
Huddinge
Website
Employees (FY)
28
Founded
2009
ISIN
SE0006343745
FIGI
BBG007H0L9R3
Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis. The company was founded by Anders Aberg, Par Nordlund, Martin Andersson, Jessica Martinsson, and Kenth Hallberg in 2009 and is headquartered in Huddinge, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SPRINT is 1.252 SEK — it has decreased by 7.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SPRINT BIOSCIENCE AB stocks are traded under the ticker SPRINT.
SPRINT BIOSCIENCE AB is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
SPRINT stock is 15.38% volatile and has beta coefficient of 0.12. Check out the list of the most volatile stocks — is SPRINT BIOSCIENCE AB there?
One year price forecast for SPRINT BIOSCIENCE AB has a max estimate of 2.900 SEK and a min estimate of 2.900 SEK.
Yes, you can track SPRINT BIOSCIENCE AB financials in yearly and quarterly reports right on TradingView.
SPRINT stock has risen by 14.44% compared to the previous week, the month change is a 22.15% rise, over the last year SPRINT BIOSCIENCE AB has showed a 67.83% increase.
SPRINT net income for the last quarter is −5.04 M SEK, while the quarter before that showed 28.62 M SEK of net income which accounts for −117.62% change. Track more SPRINT BIOSCIENCE AB financial stats to get the full picture.
Today SPRINT BIOSCIENCE AB has the market capitalization of 94.26 M, it has increased by 3.78% over the last week.
No, SPRINT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SPRINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPRINT BIOSCIENCE AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 28.00 employees. See our rating of the largest employees — is SPRINT BIOSCIENCE AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SPRINT BIOSCIENCE AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SPRINT BIOSCIENCE AB stock shows the sell signal. See more of SPRINT BIOSCIENCE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SPRINT BIOSCIENCE AB future price: according to them, SPRINT price has a max estimate of 2.90 SEK and a min estimate of 2.90 SEK. Read a more detailed SPRINT BIOSCIENCE AB forecast: see what analysts think of SPRINT BIOSCIENCE AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SPRINT BIOSCIENCE AB EBITDA is −3.29 M SEK, and current EBITDA margin is −6.51%. See more stats in SPRINT BIOSCIENCE AB financial statements.